- Home
- TTC vs ITCI Comparison
TTC vs ITCI Comparison
Compare TTC & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTC
- ITCI
- Stock Information
- Founded
- TTC 1914
- ITCI 2002
- Country
- TTC United States
- ITCI United States
- Employees
- TTC N/A
- ITCI N/A
- Industry
- TTC Tools/Hardware
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- TTC Consumer Discretionary
- ITCI Health Care
- Exchange
- TTC Nasdaq
- ITCI Nasdaq
- Market Cap
- TTC 9.4B
- ITCI 8.0B
- IPO Year
- TTC N/A
- ITCI N/A
- Fundamental
- Price
- TTC $85.59
- ITCI $75.99
- Analyst Decision
- TTC Hold
- ITCI Strong Buy
- Analyst Count
- TTC 3
- ITCI 11
- Target Price
- TTC $93.33
- ITCI $97.00
- AVG Volume (30 Days)
- TTC 942.1K
- ITCI 456.3K
- Earning Date
- TTC 09-05-2024
- ITCI 10-31-2024
- Dividend Yield
- TTC 1.68%
- ITCI N/A
- EPS Growth
- TTC 6.40
- ITCI N/A
- EPS
- TTC 3.81
- ITCI N/A
- Revenue
- TTC $4,491,000,000.00
- ITCI $564,526,000.00
- Revenue This Year
- TTC $4.78
- ITCI $46.60
- Revenue Next Year
- TTC $3.98
- ITCI $37.06
- P/E Ratio
- TTC $22.40
- ITCI N/A
- Revenue Growth
- TTC N/A
- ITCI 54.31
- 52 Week Low
- TTC $77.15
- ITCI $45.50
- 52 Week High
- TTC $102.00
- ITCI $84.89
- Technical
- Relative Strength Index (RSI)
- TTC 45.72
- ITCI 50.28
- Support Level
- TTC $81.06
- ITCI $74.46
- Resistance Level
- TTC $87.50
- ITCI $76.98
- Average True Range (ATR)
- TTC 1.95
- ITCI 1.75
- MACD
- TTC 0.16
- ITCI 0.19
- Stochastic Oscillator
- TTC 51.98
- ITCI 54.78
About TTC Toro Company (The)
The Toro Co manufactures turf maintenance and landscaping equipment. The company produces reel and rotary riding products, trim cutting and walking mowers, greens rollers, turf sprayer equipment, underground irrigation systems, heavy-duty walk-behind mowers, and sprinkler systems used for professional turf and landscape maintenance and construction. Its products are marketed through a network of distributors and dealers to predominantly professional users maintaining turfs and sports fields such as golf courses. Its operating segments are Professional which generates a substantial part of its revenue, and Residential segment. The company also produces snow plowers and ice management products. Its key revenue generating market is the United States.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.